Nocturnal temperature controlled laminar airflow for treating atopic asthma: A randomised controlled trial

Thorax

Volumn 67, Issue 3, 2012, Pages 215-221

  Boyle, Robert J ^a   Pedroletti, Christophe ^b   Wickman, Magnus ^b,c   Bjermer, Leif ^d   Valovirta, Erkka ^e   Dahl, Ronald ^f   Von Berg, Andrea ^g   Zetterström, Olof ^h   Warner, John O ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SACHS CHILDREN S HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e Terveystalo Allergy Clinic   (Finland)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g Marienhospital   (Germany)

^h LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; NITRIC OXIDE; PLACEBO;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE THERAPY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LAMINAR AIRFLOW; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SCORING SYSTEM; TEMPERATURE CONTROLLED LAMINAR AIRFLOW; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 84857443740     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200665     Document Type: Article

References (24)

1. Tunnicliffe WS, Fletcher TJ, Hammond K, et al. Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J 1999;13:654-9. (Pubitemid 29180181)
2. Peroni DG, Boner AL, Vallone G, et al. Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med 1994;149:1442-6. (Pubitemid 24175956)
3. Peroni DG, Piacentini GL, Costella S, et al. Mite avoidance can reduce air trapping and airway inflammation in allergic asthmatic children. Clin Exp Allergy 2002;32:850-5. (Pubitemid 34626081)
4. Piacentini GL, Bodini A, Costella S, et al. Allergen avoidance is associated with a fall in exhaled nitric oxide in asthmatic children. J Allergy Clin Immunol 1999;104:1323-4. (Pubitemid 30004998)
5. Piacentini GL, Peterson C, Peroni DG, et al. Allergen avoidance at high altitude and urinary eosinophil protein X. J Allergy Clin Immunol 1999;104:243-4. (Pubitemid 29364514)
6. Grootendorst DC, Dahlen SE, Van Den Bos JW, et al. Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids. Clin Exp Allergy 2001;31:400-8. (Pubitemid 34204160)
7. Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med 2004;351:1068-80. (Pubitemid 39167511)
8. Gotzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev 2008;(2):CD001187.
9. Sublett JL, Seltzer J, Burkhead R, et al. Air filters and air cleaners: rostrum by the American Academy of Allergy, Asthma & Immunology Indoor Allergen Committee. J Allergy Clin Immunol 2009;125:32-8.
10. Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Heart Lung and Blood Institute, 2006.
11. Juniper EF, Guyatt GH, Cox FM, et al. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999;14:32-8. (Pubitemid 29411232)
12. Juniper EF, Guyatt GH, Willan A, et al. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-7. (Pubitemid 24034293)
13. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-30.
14. Anon. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107-36.
15. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009;180:59-99.
16. Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008;32:545-54.
17. Demoly P, Gueron B, Annunziata K, et al. Update on asthma control in five European countries: results of a 2008 survey. Eur Respir Rev 2010;19:150-7.
18. Silvestri M, Pistorio A, Battistini E, et al. IgE in childhood asthma: relevance of demographic characteristics and polysensitisation. Arch Dis Child 2010;95:979-84.
19. Matsui EC, Sampson HA, Bahnson HT, et al. Allergen-specific IgE as a biomarker of exposure plus sensitization in inner-city adolescents with asthma. Allergy 2010;65:1414-22.
20. Pedroletti C, Millinger E, Dahlen B, et al. Clinical effects of purified air administered to the breathing zone in allergic asthma: a double-blind randomized cross-over trial. Respir Med 2009;103:1313-19.
21. Calhoun WJ. Nocturnal asthma. Chest 2003;123(3 Suppl):399S-405S. (Pubitemid 36315435)
22. Mahmic A, Tovey ER, Molloy CA, et al. House dust mite allergen exposure in infancy. Clin Exp Allergy 1998;28:1487-92. (Pubitemid 29003323)
23. Vanlaar CH, Peat JK, Marks GB, et al. Domestic control of house dust mite allergen in children's beds. J Allergy Clin Immunol 2000;105:1130-3. (Pubitemid 30418791)
24. Craig TJ. Aeroallergen sensitization in asthma: prevalence and correlation with severity. Allergy Asthma Proc 2010;31:96-102.